02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Thrombophlebitis<br />

*Note: Furosemide is a sulfonamide <strong>and</strong> can be absorbed<br />

systemically. Sulfonamides can produce severe, possibly fatal,<br />

reactions such as toxic epidermal necrolysis <strong>and</strong> Stevens–Johnson<br />

syndrome<br />

**Note: Grinspan’s syndrome is the triad of oral lichen planus,<br />

diabetes mellitus, <strong>and</strong> hypertension<br />

FUSIDIC ACID<br />

Trade names: Fucidin (Leo); Fucithalmic (Leo)<br />

Indications: Angular cheilitis, Bacterial infections, Ocular<br />

infections<br />

Category: Antibacterial<br />

Half-life: N/A<br />

Clinically important, potentially hazardous interactions<br />

with: atorvastatin, simvastatin<br />

Reactions<br />

Skin<br />

Acanthosis nigricans<br />

(1993): Teknetzis A+, JAmAcadDermatol28(3), 501<br />

Dermatitis<br />

(2000): Lee AY+, Contact Dermatitis 42(1), 53<br />

(1999): Christiansen K, Int J Antimicrob Agents 12 Suppl 2, S3<br />

(1996): Giordano-Labadie F+, Contact Dermatitis 34(2), 159<br />

(1990): Baptista A+, Contact Dermatitis 23(3), 186<br />

(1988): Hogan DJ, CMAJ 138(4), 336 (widespread)<br />

(1985): Romaguera C+, Contact Dermatitis 12(3), 176<br />

(1982): de Groot AC+, Contact Dermatitis 8(6), 429<br />

Jaundice<br />

(1993): Haddad M+, Eur J Clin Microbiol Infect Dis 12(9), 725<br />

(1983): McAreavey D+, Scott Med J 28(2), 179<br />

(1980): Humble MW+, Br Med J 280(6230), 1495 (34%)<br />

Rash (sic)<br />

(1990): Stonelake PS, BMJ 301(6763), 1281<br />

(1989): Youle MS+, J Acquir Immune Defic Syndr 2(1), 59<br />

Eyes<br />

Ocular burning<br />

(1996): Malminiemi K+, Acta Ophthalmol Sc<strong>and</strong> 74(3), 280<br />

Ocular edema<br />

(1996): Adenis JP+, Eur J Ophthalmol 6(4), 368<br />

Other<br />

Abdominal pain<br />

(1989): Youle MS+, J Acquir Immune Defic Syndr 2(1), 59<br />

Hepatotoxicity<br />

(1999): Christiansen K, Int J Antimicrob Agents 12 Suppl 2, S3<br />

Hypersensitivity<br />

(1990): Riess CE+, Lancet 335(8704), 1525<br />

Nephrotoxicity<br />

(1997): Davies JP+, Int J Clin Pract 51(4), 264<br />

(1993): Phillips AO+, NephrolDialTransplant8(6), 572<br />

Rhabdomyolysis<br />

(2003): Yuen SL+, Med J Aust 179(3), 172 (with simvastatin)<br />

(2000): Wenisch C+, Am J Med 109(1), 78 (with atorvastatin)<br />

Thrombophlebitis<br />

(1981): Iwarson S+, Sc<strong>and</strong> J Infect Dis 13(1), 65<br />

GABAPENTIN<br />

Trade name: Neurontin (Pfizer)<br />

Indications: Seizures<br />

Category: Anticonvulsant<br />

Half-life: 5–6 hours<br />

Reactions<br />

GABAPENTIN 243<br />

Skin<br />

Acne (>1%)<br />

Acute febrile neutrophilic dermatosis (Sweet’s syndrome)<br />

(2001): Popescu C, Bucharest, Romania (from Internet)<br />

(observation)<br />

(1999): Smith W (from Internet) (observation)<br />

Bullous pemphigoid<br />

(2002): Zachariae CO, Acta Derm Venereol 82(5), 396<br />

Edema<br />

(2006): Kanbay M+, Clin Neuropharmacol 29(3), 186<br />

(2003): Huber B+, Seizure 12(8), 602 (2 cases)<br />

(2002): Prescrire Int 11(60), 111<br />

(2002): Gueguen A+, Presse Med 31(33), 1559<br />

Exanthems<br />

(2003): Warnock JK+, Am J Clin Dermatol 4(1), 21<br />

(1999): DeToledo JC+, Ther <strong>Drug</strong> Monit 21(1), 137<br />

Facial edema (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!